Patheon

Patheon Inc. is a global provider of commercial manufacturing and pharmaceutical development services tailored for the pharmaceutical and biotechnology sectors. Established in 1974 and headquartered in Mississauga, Canada, the company specializes in the production of prescription and over-the-counter products in various dosage forms, including solid, semi-solid, liquid, and sterile preparations. Patheon offers a comprehensive suite of services that encompasses the entire life cycle of pharmaceutical molecules, from early development phases to late-stage development and commercial manufacturing. Their capabilities include high-potency production, sterile manufacturing, lyophilization, and controlled-release formulations. Additionally, Patheon supports clients through contract development services, which involve pre-formulation, analytical method development, pilot batch manufacturing, clinical packaging, and technology transfer to ensure successful commercial-scale production. The company delivers its products and services to approximately 120 countries, enhancing the efficiency and effectiveness of drug development and commercialization for biopharmaceutical companies.